understanding the pathway: barriers to data collection and onward referral to specialist hepatitis c...
TRANSCRIPT
Understanding the pathway: barriers to data collection and onward referral to specialist
hepatitis C services for PWUD in London
2013 LJWG pilot projects • LJWG London Consensus 2011 set out clear
recommendations
• assess the impact of the recommendations
• measured rates of testing, diagnosis and referral
• data collection proves challenging
2013 LJWG pilot projects • no funding, resources provided on a goodwill
basis • variation in existing service provision across
the sites • interim findings suggest positive impact on the
number of patients diagnosed and referred
Gilead Fellowship 2014• builds on the findings of the LJWG 2013 pilot
projects
• need for comprehensive data collection
• barriers to onward referral along the care pathway
• provide recommendations to address these barriers
Understand the barriers to data collection
Why Data Collection?• variations in infrastructure for collecting data• a lack of baseline information• lower levels of outcome data than expected• need robust data in order to secure action
from commissioners and policy makers. • good practice models to be shared
Unpack barriers in the care pathway to onward referral at
specialist services
What needs to change• only third of London boroughs has a testing-to-
treatment pathway in place • some drug treatment services in the same borough
were unaware of the pathway• variation in practice not only between boroughs, but
also between services in the same borough• barriers to onward referral prevent effective care
pathway
Public Health Report on Commissioning of HCV services in London for People who Inject Drugs, Health Service Journal, 2013
Solutions• set local treatment aspirations and monitor
achievement against them. - example Scottish Action Plan 1.
• replicable data collection systems to monitor patient pathways and assess the impact of interventions
• identify the practical changes needed in hepatitis C care pathways
1. Morris. Tackling hepatitis C: a tale of two countries. Lancet 2011; 377: 1227–1228
Methodology of Service Evaluation• mixed quantitative and qualitative design• a combination of ethnographic observation and
interviews with key personnel • Outcome measure data will be collected
through the service data collection infrastructure
• Qualitative data will be captured through surveys, interviews, focus groups and diary notes.
Who
• drug treatment services• specialist hepatitis treatment service providers• service users • commissioners • two sites in London - well established and effective parts of their services - also areas for improvement
Summary• need for better data collection
• unpack the barriers to onward referral
• provide recommendations from the findings
• help implement effective care pathways